Cargando…
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association of Internal Medicine
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338245/ https://www.ncbi.nlm.nih.gov/pubmed/37291840 http://dx.doi.org/10.3904/kjim.2022.183e |
| _version_ | 1785071589023285248 |
|---|---|
| author | Cho, Hee Jeong Jo, Jae-Cheol Lee, Yoo Jin Lee, Myung Won Kim, Do Young Shin, Ho Jin Im, Sung Nam Lee, Ji Hyun Bae, Sung Hwa Do, Young Rok Lee, Won Sik Kim, Min Kyung Jung, Jina Lee, Jung Min Kim, Ju-Hyung Baek, Dong Won Sohn, Sang-Kyun Moon, Joon Ho |
| author_facet | Cho, Hee Jeong Jo, Jae-Cheol Lee, Yoo Jin Lee, Myung Won Kim, Do Young Shin, Ho Jin Im, Sung Nam Lee, Ji Hyun Bae, Sung Hwa Do, Young Rok Lee, Won Sik Kim, Min Kyung Jung, Jina Lee, Jung Min Kim, Ju-Hyung Baek, Dong Won Sohn, Sang-Kyun Moon, Joon Ho |
| author_sort | Cho, Hee Jeong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10338245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Korean Association of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103382452023-07-14 Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma Cho, Hee Jeong Jo, Jae-Cheol Lee, Yoo Jin Lee, Myung Won Kim, Do Young Shin, Ho Jin Im, Sung Nam Lee, Ji Hyun Bae, Sung Hwa Do, Young Rok Lee, Won Sik Kim, Min Kyung Jung, Jina Lee, Jung Min Kim, Ju-Hyung Baek, Dong Won Sohn, Sang-Kyun Moon, Joon Ho Korean J Intern Med Erratum Korean Association of Internal Medicine 2023-07 2023-06-09 /pmc/articles/PMC10338245/ /pubmed/37291840 http://dx.doi.org/10.3904/kjim.2022.183e Text en Copyright ©2023 The Korean Association of Internal Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Erratum Cho, Hee Jeong Jo, Jae-Cheol Lee, Yoo Jin Lee, Myung Won Kim, Do Young Shin, Ho Jin Im, Sung Nam Lee, Ji Hyun Bae, Sung Hwa Do, Young Rok Lee, Won Sik Kim, Min Kyung Jung, Jina Lee, Jung Min Kim, Ju-Hyung Baek, Dong Won Sohn, Sang-Kyun Moon, Joon Ho Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title | Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title_full | Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title_fullStr | Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title_full_unstemmed | Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title_short | Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| title_sort | predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338245/ https://www.ncbi.nlm.nih.gov/pubmed/37291840 http://dx.doi.org/10.3904/kjim.2022.183e |
| work_keys_str_mv | AT choheejeong predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT jojaecheol predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT leeyoojin predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT leemyungwon predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT kimdoyoung predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT shinhojin predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT imsungnam predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT leejihyun predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT baesunghwa predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT doyoungrok predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT leewonsik predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT kimminkyung predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT jungjina predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT leejungmin predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT kimjuhyung predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT baekdongwon predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT sohnsangkyun predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma AT moonjoonho predictiveroleofabsolutelymphocytecountindaratumumabtreatedpatientswithrelapsedrefractorymultiplemyeloma |